131
Participants
Start Date
August 24, 2021
Primary Completion Date
May 7, 2024
Study Completion Date
June 4, 2024
CSB-001 Ophthalmic Solution 0.1%
CSB-001: human recombinant dHGF (5-amino acid deleted hepatocyte growth factor)
Vehicle Control
Matching vehicle control without the drug substance
SightMD, Babylon
Cornea Consultants of Albany, Slingerlands
UPMC Eye Center, Pittsburgh
Hazleton Eye Specialists, Hazle Township
Scheie Eye Institute, Philadelphia
Johns Hopkins Hospital, Baltimore
Virginia Eye Consultants, Norfolk
Duke Eye Center, Durham
Carolina Cataract & Laser Center, Ladson
Eye Consultants of Atlanta, Atlanta
International Eye Associates, PA, Ormond Beach
Bowden Eye and Associates, Jacksonville
Bascom Palmer Eye Institute at Palm Beach Gardens, Palm Beach
Advanced Research, Boynton Beach
International Research Center, Tampa
BLINK Research Center, LLC, Memphis
Kentucky Eye Institute, Lexington
Cincinnati Eye Institute, Edgewood
The Ohio State University, Department of Ophthalmology and Visual Sciences, Columbus
Price Vision Group, Indianapolis
Midwest Cornea Associates, LLC, Carmel
Minnesota Eye Consultants, Minnetonka
Cornea and Contact Lens Institute of Minnesota, Edina
Vance Thompson Vision, Sioux Falls
Eye Consultants of North Dakota, Fargo
Ophthalmology Associates, St Louis
Tauber Eye Center, Kansas City
Stuart A. Terry, MD PA, San Antonio
University of Texas at Austin; The Mitchel and Shannon Wong Eye Institute, Austin
University of Colorado - Dept. of Ophthalmology, Aurora
Corneal Consultants of Colorado, Littleton
Vision Institute, Colorado Springs
Eye Care North, Cave Creek
Nvision Clinical Research, LLC, Los Angeles
Global Research Foundation, Los Angeles
UCLA Stein Eye Institute, Los Angeles
Atlantis Eyecare, Torrance
California Eye Specialists Medical Group Inc., Pasadena
Gordon Schanzlin New Vision Institute, San Diego
Loma Linda University Eye Institute, Loma Linda
LoBue Laser and Eye Medical Center, Inc., Murrieta
Martel Eye Medical Group, Rancho Cordova
Devers Eye Institute, Portland
Tufts Medical Center, Boston
Metropolitan Eye Research and Surgery Institute, Palisades Park
Dr. Gregory Moloney, Vancouver
Precision Cornea Centre, Ottawa
Kensington Eye Institute, Toronto
Lead Sponsor
Claris Biotherapeutics, Inc.
INDUSTRY